Patents filed in the U.S. vs. Japan for the top selling drugs U.S. August 2020

Patents filed in the U.S. vs. Japan for top selling drugs in the United States, as of August 2020 (by multiplier)

Patents filed in the U.S. vs. Japan for top selling U.S. drugs, as of August 2020

Last update:

Jul 4, 2025

Author:

��ƽ�� Research Department

Regions:

Japan, United States

Survey time period:

From 01/08/2020 to 31/08/2020

As of August 2019, the number of patents filed for the drug Humira in the United States were 4.1 times the number of patents also filed for it in Japan. This statistic illustrates the number of patents filed in the U.S. vs. Japan for top selling drugs in the United States, as of August 2020, by multiplier.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Patents filed in the U.S. vs. Japan for top selling drugs in the United States, as of August 2020 (by multiplier)

Get in touch with us for additional information

��ƽ��